Age (years), median (IQR) |
78 (61 to 86) |
Gender, n (%) female |
58 (54.2%) |
Clinical unit, n (%)
Medical
Surgical
|
63 (58.9%)
44 (41.1%)
|
Infection type (n=112) (%)
intra-abdominal
lower respiratory tract
urinary tract
skin and soft tissue
prophylaxis
gastro-intestinal tract
Other
|
35 (31.2%)
31 (27.7%)
22 (19.6%)
15 (13.4%)
4 (3.8%)
2 (1.9%)
3 (2.7%)
|
Intravenous antimicrobials (n=164) (%)
ceftriaxone
amoxicillin-clavulanate
metronidazole
benzylpenicillin
cefazolin
azithromycin
piperacillin-tazobactam
ampicillin
gentamicin
flucloxacillin
meropenem
other
|
46 (28.0%)
25 (15.2%)
19 (11.6%)
14 (8.5%)
13 (7.9%)
10 (6.1%)
9 (5.5%)
7 (4.3%)
6 (3.7%)
4 (2.4%)
3 (1.8%)
8 (4.9%)
|